Quantitative PCR-ELAHA for the determination of retroviral vector transduction efficiency

15Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Current methods to detect transduction efficiency during the routine use of integrating retroviral vectors in gene therapy applications may require the use of radioactivity and usually rely upon subjective determination of the results. We have developed two competitive quantitative assays that use an enzyme-linked, amplicon hybridization assay (ELAHA) to detect the products of PCR-amplified regions of transgene from cells transduced with Moloney murine leukemia virus vectors. The quantitative assays (PCR-ELAHA) proved to be simple, rapid, and sensitive, avoiding the need for Southern hybridization, complex histochemical stains, or often subjective and time-consuming tissue culture and immunofluorescence assays. The PCR-ELAHA systems can rapidly detect proviral DNA from any retroviral vector carrying the common selective and marker genes neomycin phosphotransferase and green fluorescent protein, and the methods described are equally applicable to other sequences of interest, providing a cheaper alternative to the evolving real-time PCR methods. The results revealed the number of copies of retrovector provirus present per stably transduced cell using vectors containing either one or both qPCR targets.

Cite

CITATION STYLE

APA

Mackay, I. M., Metharom, P., Sloots, T. P., & Wei, M. Q. (2001). Quantitative PCR-ELAHA for the determination of retroviral vector transduction efficiency. Molecular Therapy, 3(5 I), 801–808. https://doi.org/10.1006/mthe.2001.0320

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free